Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
1999-08-27
2001-05-01
Tate, Christopher R. (Department: 1651)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C514S816000, C514S885000
Reexamination Certificate
active
06224875
ABSTRACT:
TECHNICAL FIELD
The present invention relates to a
Tanacetum parthenium
extract substantially free of &agr;-unsaturated &ggr;-lactones. The invention additionally relates to a process for the preparation of the extract and to pharmaceutical and cosmetic compositions containing a
Tanacetum parthenium
extract which is substantially free of parthenolide.
TECHNOLOGICAL BACKGROUND
Extracts of
Tanacetum parthenium
, a plant belonging to the family Asteracee/Composite, also known as Altamisa, Crisanthemum, Leucanthemum,
Pyrethrum parthenium
as well as under the common name “feverfew”, have traditionally been used in the treatment of migraine, vertigo, arthritis, menstrual disorders, fever, toothache, stomach ache and insect bites. Extracts of
Tanacetum parthenium
contain various volatile oils having mono- and/or sesquiterpene components, flavonoids, tannins, and pyrethrin, as well as terpenoids of the family of sesquiterpene lactones known as germacranolides, guaianolides and eudesmanolides. These latter compounds are characterized by an &agr;-unsaturated &ggr;-lactone structure and comprise in particular the compounds known as parthenolide, 3-&bgr;-hydroxy-parthenoide, costunolide, 3-&bgr;-hydroxy-costunolide, artemorin, 8-&agr;-hydroxy-estafiatin and chrysanthemonin. The presence of these sesquiterpene lactones is considered necessary for the extracts to achieve pharmacological activity (J. Pharm. Pharmacol. 1992, 44:391-395).
Particular attention has been focused on parthenolide, which is thought to be the fundamental active ingredient of these extracts, but which is also responsible for allergic reactions which can sometimes occur following treatment with the extracts of
Tanacetum parthenium
(See, for example, Arch. Dermatol. Forsch. 1975, 251 (3):235-44; Arch. Dermatol. Forsch. 1976, 255 (2):111-21; Contact Dermatitis, 1988, 38 (4):207-8; Am. J. Contact Dermatol. 1998-9 (1):49-50; Br. J. Dermatol. 1995, 132 (4):543-7). Extracts of
Tanacetum parthenium
containing parthenolide are disclosed in WO 94 06800; EP 0 553 658; WO 92 11857; GB 2,166,952; EP 98 041; WO 98 39018.
SUMMARY OF THE INVENTION
In a first embodiment the invention is directed to a
Tanacetum parthenium
extract which is substantially free of &agr;-unsaturated &ggr;-lactones. In a preferred embodiment, the content of &agr;-unsaturated &ggr;-lactone is below 0.2 wt %. More preferably, the &agr;-unsaturated &ggr;-lactones are present in an amount of no more than 0.1 wt. %.
In a further embodiment the extract is substantially free of parthenolide. Preferably the parthenolide content is below 0.2 wt. %, and more preferably below 0.1 wt. %.
In another embodiment, the invention is directed to a
Tanacetum parthenium
extract which is obtainable by a process comprising the steps of:
(a) extracting a quantity of plant material from an aerial portion of
Tanacetum parthenium
with a solvent selected from the group consisting of acetone, an alcohol and mixtures of acetone or an alcohol with water, to form a first extract;
(b) extracting the first extract with a hydrocarbon solvent to produce a second extract having a hydrocarbon phase and a non-hydrocarbon phase;
(c) evaporating the hydrocarbon phase from the second extract to form a first residue;
(d) extracting the non-hydrocarbon phase with a non-polar solvent to form a third extract;
(e) evaporating the non-polar solvent portion of the third extract to produce a second residue and redissolving the second residue in a water-alcoholic solution of acid;
(f) adding to the water-alcoholic solution a quantity of a strongly basic resin;
(g) eluting the resin with an alcohol solution and separating the eluate from the resin;
(h) treating the resin with an alcoholic or water-alcoholic solution of an acid;
(i) concentrating the alcoholic or water-alcoholic solution to form a third residue;
(j) extracting the third residue with a non-polar solvent to produce a fourth extract;
(k) evaporating the non-polar solvent from step (j) to form a fourth residue;
(l) combining the first and the fourth residues with the third extract to form a mixture;
(m) evaporating a liquid portion of the mixture to form a fifth residue; and
(n) at least partially drying the fifth residue.
Still further, the invention is directed to a pharmaceutical composition containing an extract as described herein in admixture with a pharmaceutically acceptable carrier.
The invention is additionally directed to a process for forming an extract of
Tanacetum parthenium
substantially free of &agr;-unsaturated &ggr;-lactone which comprises the method steps set forth above.
REFERENCES:
patent: 4758433 (1988-07-01), Johnson et al.
patent: 5384121 (1995-01-01), Rhodes
patent: 5466451 (1995-11-01), Beuscher et al.
patent: 9348241 (1994-04-01), None
Sumner et al. Biochem. Pharmacol. vol. 43 (11), pp. 2313-2320, 1992.*
Heptinstall et al. ACS Symp. Ser. vol. 691 (Phytomedicines of Europe), pp. 158-175, 1998.*
Dornelles et al. Rev. Bras. Farm. vol. 79 (1/2), pp. 42-44, abstract enclosed, 1998.*
Lamminpaa et al. Contact Dermatitis, vol. 34 (5), pp. 330-335, abstract enclosed, 1996.*
Weerdt et al. Phytomed. vol. 3 (3), pp. 225-230, abstract enclosed, 1996.*
Barsby et al. Planta Med. vol. 59, pp. 20-25, 1992.*
Hausen et al. Acta Derm.-Venereol. vol. 63 (4), pp. 308-314, abstract enclosed, 1983.*
Hausen, B.M. Dermatosen in Beruf und Umwelt. vol. 29 (1), pp. 18-21, abstract enclosed, 1981.*
Williams et al. Phytochem. vol. 38, No. 1, pp. 267-270, 1995.
Bombardelli Ezio
Morazzoni Paolo
Indena S.p.A.
Pennie & Edmonds LLP
Tate Christopher R.
LandOfFree
Tanacetum parthenium extract and method of obtaining same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tanacetum parthenium extract and method of obtaining same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tanacetum parthenium extract and method of obtaining same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2557887